Earnings & Reporting

BNY Mellon's steady dividend offers a window into the high-yield debt market, a crucial, high-risk funding source for the mining sector's energy transition.

Beyond the gas pump, Casey's is winning with a savvy M&A strategy and a food service empire that rivals fast-food chains. Here’s what it means.

A new neuroscience framework reveals why ethical leaders attract criticism, shifting the focus from leadership flaws to the observer's own brain.

Coveo manages a key executive transition by doubling down on its AI-driven growth story, reassuring investors that its innovation engine remains in high gear.

Apollo Commercial Real Estate Finance offers a tempting 10% yield, but can it last? We dive into the risks and rewards of this high-stakes CRE play.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A Chinese firm's entry into Germany's EV market seems distant from medicine, but its tricycle vehicle could be the key to a greener, faster last-mile for healthcare.

Marriott's latest survey and massive points giveaway reveal a strategic pivot to capture a historic shift in consumer spending from goods to travel.

With its 2026 Investor Day nearing, PHINIA aims to prove its dual-path strategy is the key to powering a diverse, carbon-conscious industrial future.

Same-day delivery is no longer just about speed. It's enabling DTC brands to sell what was once unshippable, transforming product lines and logistics.

Beyond a simple product launch, a strategic acquisition is fueling innovations in drug delivery that could transform patient care for millions worldwide.

Beyond e-commerce, GigaCloud's massive new NJ facility signals a strategic move to fortify trans-pacific supply lines for large goods, impacting US economic competitiveness.

The space tourism pioneer is restructuring its debt, buying precious time for its next-gen fleet but at a steep cost for shareholders and future finances.

Beyond a simple transaction, Foresight Group's ongoing share repurchase signals deep confidence and a commitment to disciplined capital management.

Amid rapid expansion and heightened regulatory scrutiny, PACS Group hires new compliance and HR chiefs to fortify its operational foundation for the future.

Guangdong Jiaying Pharma is leveraging its unique Hakka heritage to enter the global market. But can ancient wisdom navigate modern regulatory and corporate hurdles?

Following a major clinical trial win, Kymera Therapeutics seeks $500M. We break down the high-stakes strategy behind funding a new era of medicine.

Prospect Enhanced Yield Fund's debut 9% distribution tempts income seekers, but a look into the structured credit market reveals a complex risk-reward.

As CEO J.K. Symancyk prepares for a key investor conference, Signet Jewelers' new strategy faces the test of a market transformed by tech and ethics.

ATI Inc. names operational veteran Rob Foster as its new CFO, signaling a strategic bet that manufacturing prowess is the key to financial success.